Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ototoxicity 1Liver Neoplasms 1Hepatoblastoma 1

Interventions

toripalimab 1sodium thiosulfate 1naxitamab 1Vincristine 1Rituximab 1Methotrexate 1Granulocyte-Macrophage Colony-Stimulating Factor 1Eflornithine 1Drug Therapy 1Doxorubicin 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Has announcements × sodium thiosulfate × Clear all
NCT00652132 2018-05-29

SIOPEL6

University of Birmingham

Phase 3 Completed
116 enrolled 1 FDA
Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡